Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Albert CM, Mittleman MA, Chae CU et al. (2000) Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med 343: 1355–1361
Albert CM, Campos H, Stampfer MJ et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346: 1113–1118
Angelini P, Velasco JA, Flamm S (2002) Coronary anomalies: incidence, pathophysiology, and clinical relevance. Circulation 105: 2449–2454
AVID-Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337: 1576–1583
Bansch D, Antz M, Boczor S et al. (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105: 1453–1458
Bardy GH (2004) SCD-HeFT. ACC 2004 (Abstract)
Bayes de Luna A, Coumel P, Leclercq JF (1989) Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 117: 151–159
Beuckelmann DJ, Nabauer M, Erdmann E (1993) Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. Circ Res 73: 379–385
Bigger JT Jr (1986) Relation between left ventricular dysfunction and ventricular arrhythmias after myocardial infarction. Am J Cardiol 57: 8B–14B
Billman GE (2002) Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention. J Appl Physiol 92: 446–454
Billman GE, Kang JX, Leaf A (1999) Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 99: 2452–2457
Brugada J, Brugada P (1997) Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol 8: 325–331
Brugada R, Hong K, Dumaine R et al. (2004) Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109: 30–35
Burr ML, Fehily AM, Gilbert JF et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2: 757–761
Buxton AE, Lee KL, Fisher JD et al. (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341: 1882–1890
Caffrey SL, Willoughby PJ, Pepe PE, Becker LB (2002) Public use of automated external defibrillators. N Engl J Med 347: 1242–1247
Cairns JA, Connolly SJ, Roberts R, Gent M (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 349: 675–682
CAST-Investigators (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321: 406–412
Cleland JGF, Erhardt L, Murry G et al. (1997) Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. Eur Heart J 18: 41–51
Cleland JG, Cohen-Solal A, Aguilar JC et al. (2002) Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360: 1631–1639
Connolly SJ, Gent M, Roberts RS et al. (2000a) Canadian implantable de-fibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101: 1297–1302
Connolly SJ, Kerr CR, Gent M et al. (2000b) Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 342: 1385–1391
Corrado D, Basso C, Nava A, Thiene G (2001) Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev 9: 259–265
Dargie HJ (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357: 1385–1390
Daubert JP, Zareba W, Schuger CD et al. (2003) Does EPS inducibility in MADIT II patients predict subsequent VT and/or VF events? Pacing Clin Electrophysiol 26: (part II) 960
Dauchot P, Gravenstein JS (1971) Effects of atropine on the electrocardiogram in different age groups. Clin Pharmacol Ther 12: 274–280
Domanski MJ, Exner DV, Borkowf CB et al. (1999) Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33: 598–604
Dorian P, Cass D, Schwartz B et al. (2002) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346: 884–890
Feld GK, Fleck P, Chen PS et al. (1992) Radiofrequency catheter ablation for the treatment of human type 1 atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 86: 1233–1240
Friedlander Y, Siscovick DS, Weinmann S et al. (1998) Family history as a risk factor for primary cardiac arrest. Circulation 97: 155–160
Fuster V, Ryden LE, Asinger RW et al. (2001) ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Circulation 104: 2118–2150
GISSI-Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 354: 447–455
Gold MR, Spencer W (2003) T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol 18: 1–5
Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE (2002) Guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106: 2145–2161
Haddad PM, Andersen IM (2002) Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 62: 1649–1671
Haverkamp H, Breithardt G (2003) Moderne Herzrhythmustherapie. Thieme, Stuttgart
Hine LK, Laird N, Hewitt P, Chalmers TC (1989) Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 149: 2694–2698
Hoppe UC, Erdmann E (2001) Leitlinien zur Therapie der chronischen Herzinsuffizienz. Im Auftrag der Deutschen Gesellschaft für Kardiologie. Z Kardiol 90: 218–237
Hoppe UC, Marbán E, Johns DC (2001) Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1. Proc Natl Acad Sci USA 98: 5335–5340
Huikuri HV, Castellanos A, Myerburg RJ (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345: 1473–1482
Januzzi JL Jr., Stern TA, Pasternak RC, DeSanctis RW (2000) The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 160: 1913–1921
Jessup M (2003) Aldosterone blockade and heart failure. N Engl J Med 348: 1380–1382
Jose AD, Collison D (1970) The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 4: 160–167
Julian DG, Camm AJ, Frangin G et al. (1997) Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349: 667–674
Jung W, Anderson M, Camm AJ et al. (1997) Recommendations for driving of patients with implantable cardioverter defibrillators. Study Group on ‘ICD and Driving’ of the Working Groups on Cardiac Pacing and Arrhythmias of the European Society of Cardiology. Eur Heart J 18: 1210–1219
Kass RS, Moss AJ (1985) Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest 112: 810–815
Kennedy HL, Whitlock JA, Sprague MK et al. (1985) Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 312: 193–197
Kirchhof P, Eckardt L, Loh P et al. (2002) Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial. Lancet 360: 1275–1279
Kuck KH, Cappato R, Siebels J, Ruppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102: 748–754
Kuller LH (1980) Sudden death-definition and epidemiologic considerations. Prog Cardiovasc Dis 23: 1–12
Lamas GA, Orav EJ, Stambler BS et al. (1998) Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 338: 1097–1104
Lamas GA, Lee KL, Sweeney MO et al. (2002) Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 346: 1854–1862
Lee RJ, Kalman JM, Fitzpatrick AP et al. (1995) Radiofrequency catheter modification of the sinus node for «inappropriate» sinus tachycardia. Circulation 92: 2919–2928
MacMahon S, Collins R, Peto R et al. (1988) Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. Jama 260: 1910–1916
Manz M, Mletzko R, Jung W, Luderitz B (1992) Electrophysiological and haemodynamic effects of lidocaine and ajmaline in the management of sustained ventricular tachycardia. Eur Heart J 13: 1123–1128
Maron BJ, Olivotto I, Spirito P et al. (2000) Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 102: 858–864
Massie BM, Fisher SG, Deedwania PC et al. (1996) Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation 93: 2128–2134
Meisel SR, Kutz I, Dayan KI et al. (1991) Effect of Iraqi missile war on incidence of acute myocardial infarction and sudden death in Israeli civilians. Lancet 338: 660–661
Moss AJ, Hall WJ, Cannom DS et al. (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335: 1933–1940
Moss AJ, Zareba W, Hall WJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877–883
Myerburg RJ, Spooner PM (2001) Opportunities for sudden death prevention: directions for new clinical and basic research. Cardiovasc Res 50: 177–185
Myerburg RJ, Kessler KM, Castellanos A (1993) Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119: 1187–1197
Myerburg RJ, Mitrani R, Interian A Jr, Castellanos A (1998) Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97: 1514–1521
Nattel S (1999) Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities: cause, consequence, or innocent bystander? Circ Res 85: 473–476
Pappone C, Oreto G, Rosanio S et al. (2001) Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104: 2539–2544
Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–717
Pitt B, Remme W, Zannad F et al. (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348: 1309–1321
Priori SG (2004) Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ Res 94: 140–145
Priori SG, Aliot E, Blomstrom-Lundqvist C et al. (2001) Task Force on Sudden Cardiac Death of the European Society of Cardiology. Eur Heart J 22: 1374–1450
Roy D, Talajic M, Dorian P et al. (2000) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med 342: 913–920
Singh SN, Flechter RD, Fisher SG et al. (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333: 77–82
Siscovick DS, Raghunathan TE, Psaty BM et al. (1994) Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 330: 1852–1857
Stellbrink C, Nixdorff U, Hofmann T et al. (2004) Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. Circulation 109: 997–1003
Struthers AD (2002) Impact of aldosterone on vascular pathophysiology. Congest Heart Fail 8: 18–22
Tebbenjohanns J, Niehaus M, Korte T (2002) Indikationen für den implantierbaren Kardioverterdefibrillator. Dtsch Med Wochenschr 127: 2120–2124
Tomaselli GF, Rose J (2000) Molecular aspects of arrhythmias associated with cardiomyopathies. Curr Opin Cardiol 15: 202–208
Van Gelder IC, Hagens VE, Bosker HA et al. (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347: 1834–1840
Waldo AL, Camm AJ, deRuyter H et al. (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348: 7–12
Wyse DG, Waldo AL, DiMarco JP et al. (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347: 1825–1833
Zipes DP, DiMarco JP, Gillette PC et al. (1995) Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 26: 555–573
Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98: 2334–51
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Hoppe, C. (2006). Rhythmusstörungen des Herzens. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29425-2_3
Download citation
DOI: https://doi.org/10.1007/3-540-29425-2_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23742-6
Online ISBN: 978-3-540-29425-2
eBook Packages: Medicine (German Language)